BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 16888437)

  • 1. Aspirin resistance: is this term meaningful?
    Violi F; Pignatelli P
    Curr Opin Hematol; 2006 Sep; 13(5):331-6. PubMed ID: 16888437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
    Cattaneo M
    Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin resistance.
    Tantry US; Mahla E; Gurbel PA
    Prog Cardiovasc Dis; 2009; 52(2):141-52. PubMed ID: 19732606
    [No Abstract]   [Full Text] [Related]  

  • 5. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
    Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
    Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of aspirin resistance.
    Patel D; Moonis M
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):969-75. PubMed ID: 17867925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of biological relevance of platelet cyclooxygenase-2 dependent thromboxane A2 production.
    Riondino S; Trifirò E; Principessa L; Mascioletti S; Di Renzo L; Gaudio C; Biasucci LM; Crea F; Pulcinelli FM
    Thromb Res; 2008; 122(3):359-65. PubMed ID: 18295304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.
    Nielsen HL; Kristensen SD; Thygesen SS; Mortensen J; Pedersen SB; Grove EL; Hvas AM
    Thromb Res; 2008; 123(2):267-73. PubMed ID: 18499236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aspirin resistance controversy: clinical entity or platelet heterogeneity?
    Freedman JE
    Circulation; 2006 Jun; 113(25):2865-7. PubMed ID: 16801473
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A brief review on high on-aspirin residual platelet reactivity.
    Pettersen AA; Arnesen H; Seljeflot I
    Vascul Pharmacol; 2015; 67-69():6-9. PubMed ID: 25869498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a definition of aspirin resistance: a typological approach.
    Weber AA; Przytulski B; Schanz A; Hohlfeld T; Schrör K
    Platelets; 2002 Feb; 13(1):37-40. PubMed ID: 11918835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug insight: aspirin resistance--fact or fashion?
    Patrono C; Rocca B
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical importance of aspirin resistance].
    Hirmerová J; Filipovský J
    Vnitr Lek; 2004 Jun; 50(6):462-9. PubMed ID: 15346640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin-induced platelet inhibition in patients undergoing cardiac surgery.
    Zimmermann N; Kurt M; Winter J; Gams E; Wenzel F; Weber AA; Hohlfeld T
    Platelets; 2007 Nov; 18(7):528-34. PubMed ID: 17957569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can platelet function tests predict the clinical efficacy of aspirin?
    Haubelt H; Anders C; Hellstern P
    Semin Thromb Hemost; 2005; 31(4):404-10. PubMed ID: 16149017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease.
    Grove EL; Hvas AM; Johnsen HL; Hedegaard SS; Pedersen SB; Mortensen J; Kristensen SD
    Thromb Haemost; 2010 Jun; 103(6):1245-53. PubMed ID: 20352155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.